Tms Clinical Solutions

What Tms Clinical Solutions does

TMS Clinical Solutions is a Texas-based private healthcare services company that delivers FDA-approved Deep Transcranial Magnetic Stimulation (TMS) therapy for treatment-resistant depression, with additional indications referenced for OCD and smoking addiction. The core technology uses targeted magnetic fields applied via a coil near the scalp to stimulate under-active neurons in the left dorsolateral prefrontal cortex; treatment consists of roughly 20-minute daily sessions over a 6-8 week course, with reported response and remission rates of approximately 75% and 50% respectively. Patient services are delivered through a network of seven affiliated psychiatric practices across the DFW, Austin, and Houston metros, while TMS Clinical Solutions centralizes marketing, scheduling, insurance verification, and patient acquisition; a dedicated provider-referral portal and an online symptom-assessment quiz serve as the primary digital funnels.

The company operates a hybrid revenue model. The patient-services line is reimbursed by insurance (all major payers are accepted for depression) on a per-treatment-course basis, functioning as recurring revenue tied to patient throughput. A second, B2B line markets a subscription consulting service to psychiatry practices wanting to launch TMS programs, priced starting at $995 per month and covering credentialing, equipment procurement, market analysis, staff hiring, and operational setup; the company states it has helped open 75+ clinics with 50+ years of combined team experience. A sister company, TMS Marketing Solutions, provides patient-acquisition and marketing-automation services integrated with the HighLevel platform, monetized as managed services to fill clinic capacity.

Founded around 2022 and operating from Southlake, Texas with 11-50 employees, TMS Clinical Solutions is privately held with no disclosed institutional investors or funding rounds. Its distribution leverages partner psychiatry practices rather than owned clinic real estate, which reduces capital intensity but ties clinical capacity to independent physician practices. Strategic emphasis appears to be on consolidating Texas metro coverage and growing the higher-margin consulting and marketing subscription streams alongside patient care.

Name

Tms Clinical Solutions

Legal name

TMS Clinical Solutions

Website

https://tmsclinicalsolutions.com

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

1–10 employees

Short description

TMS Clinical Solutions is a Texas-based private healthcare company that delivers FDA-approved TMS therapy for treatment-resistant depression through a network of seven affiliated psychiatry practices in DFW, Austin, and Houston, and sells a subscription consulting service ($995/month) and a sister marketing company to help other practices launch TMS clinics.

Ownership category

akta.pro rank

Product category

Transcranial Magnetic Stimulation Therapy

NAICS

Offices of Physicians, Mental Health Specialists (621112), Outpatient Mental Health and Substance Abuse Centers (62142)

SIC

Services-Health Services (8000), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

General Mental Health Therapy Platforms (Talk Therapy) (HLALAEAA)

Keywords

• Transcranial magnetic stimulation
• Treatment-resistant depression
• Mental health services
• Psychiatric practice consulting
• Non-invasive brain stimulation

Headquarters

HQ city

Southlake

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. TMS Treatment Services: Direct patient care revenue through insurance reimbursements for transcranial magnetic stimulation treatments. Treatment course typically spans 6-8 weeks with daily sessions. All major insurance payers cover TMS for depression.
2. Practice Consulting Services: Consulting fees for helping other psychiatric practices launch TMS programs. Services include credentialing optimization, equipment procurement guidance, market analysis, staff recruitment, and operational setup. Starting at $995/month subscription model.
3. Marketing Services: Sister company (TMS Marketing Solutions) provides marketing services to fill TMS clinic chairs and scale practices. Integration with HighLevel platform for lead capture and patient acquisition.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

TMS Clinical Solutions delivers FDA-approved Transcranial Magnetic Stimulation therapy for treatment-resistant major depressive disorder, anxious depression, and OCD through a network of partner psychiatrists across the DFW, Austin, and Houston metros. A typical course involves daily 20-minute sessions over 6-8 weeks, with reported outcomes of about 75% of patients showing clinically meaningful response and about 50% achieving full remission. The company additionally sells a $995/month subscription consulting service to help psychiatry practices launch TMS programs, covering credentialing, equipment procurement, market analysis, and staff recruitment. A sister company, TMS Marketing Solutions, supplies lead-generation and patient-acquisition services to partner clinics.

Product overview

Tms Clinical Solutions operates as a TMS therapy provider and consultancy. The core offering is FDA-approved transcranial magnetic stimulation (TMS) therapy for treatment-resistant depression, delivered through partner providers in DFW, Austin, and Houston areas. The company also offers consulting services (under 'Get More TMS Patients') to help other practices launch TMS clinics, with 50+ years of combined TMS experience and having helped open 75+ clinics. A sister company, TMS Marketing Solutions, provides patient acquisition and marketing automation tools. The main treatment offering is delivered via the core TMS Therapy product, with consulting and marketing as complementary service lines.

Differentiator

Problem solved

Functional benefit

Products and services

• TMS Therapy (Transcranial Magnetic Stimulation) FDA-approved non-invasive brain stimulation therapy for treatment-resistant major depressive disorder, anxious depression, and OCD that uses targeted magnetic fields to stimulate under-active neurons in the left dorsolateral prefrontal cortex. Delivered through 7 partner psychiatry practices across the DFW, Austin, and Houston metros as a 6-8 week course of daily 20-minute sessions. Reported patient outcomes: about 75% clinically meaningful response and about 50% full remission. Covered by all major insurance payers.
• TMS Clinic Launch Consulting Subscription consulting service for psychiatry and behavioral health practices that want to launch a TMS service line. Covers insurance credentialing optimization, equipment procurement guidance, market analysis, staff recruitment and training, and operational setup. Priced from $995/month with a $1,000 qualification offer.

Quantifiable outcome

• 75% of patients show clinically meaningful response after completing full TMS course
• +3 more outcomes

Named customers6 records

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Eight partnerships are on record, tiered core.

• TMS Marketing SolutionscoreGTM or Marketing PartnerSister company providing marketing services specifically for TMS clinics. Offers lead generation, patient acquisition, and practice scaling services through the HighLevel platform. Enables partner practices to fill their treatment chairs and grow revenue.
• Southlake PsychiatrycoreChannel Partner/ Reseller/ DistributorPartner provider led by Dr. Rhema Jacob, DO, board-certified psychiatrist in Southlake, TX with 7 years of experience. Delivers TMS treatment services to patients referred through TMS Clinical Solutions.
• Thrive Psychiatry and WellnesscoreChannel Partner/ Reseller/ DistributorPartner provider led by Dr. Swati Ellendula, MD, board-certified psychiatrist in Frisco, TX with over 15 years of experience. Affiliated through friscobehavioralhealth.com for TMS treatment delivery.
• Neogen PsychiatrycoreChannel Partner/ Reseller/ DistributorPartner provider led by Dr. Eugene Fletcher, DO, board-certified psychiatrist in Southlake, TX with over 21 years of experience. Provides TMS services through neogenpsych.com.
• Center for Integrative PsychiatrycoreChannel Partner/ Reseller/ DistributorPartner provider led by Dr. Tahir Khwaja at texascip.com. Delivers TMS treatment services as part of integrative psychiatric care.
• TMS of AustincoreChannel Partner/ Reseller/ DistributorPartner provider led by Dr. Ramon Aragon, providing TMS services in the Austin, TX metropolitan area through tmsofaustin.com.
• Exult HealthcarecoreChannel Partner/ Reseller/ DistributorPartner provider led by Dr. Deepika Bhargava, offering TMS treatment services in the Texas market through exulthealthcare.com.
• Texas Pain PsychiatrycoreChannel Partner/ Reseller/ DistributorPartner provider led by Dr. Raza Sayed, providing TMS services through texaspainpsychiatry.com for patients with comorbid pain and psychiatric conditions.

Scale indicators6 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Amen Clinics: Multi-clinic brain-health and psychiatry practice using imaging plus novel neuromodulation therapies. Comparable as a psychiatric practice group offering non-pharmaceutical brain-based treatments for depression, though a larger, broader incumbent.
• BrainsWay: Maker of FDA-cleared Deep TMS systems for depression, OCD, and smoking cessation. The technology underlying TMS Clinical Solutions' offerings (Deep TMS for depression/OCD/smoking addiction) is built on BrainsWay's platform, making them a directly comparable device-side incumbent.
• Neuronetics (NeuroStar): Manufacturer of the NeuroStar TMS device and operator of treatment centers, supplies devices and protocols to many U.S. TMS clinics including independent operators. Comparable as the incumbent upstream supplier whose products enable the kind of therapy TMS Clinical Solutions delivers through its partners.

Direct peers

• Success TMS: Regional operator of insurance-covered TMS clinics serving treatment-resistant depression patients across multiple U.S. states. Highly comparable given identical outpatient neurostimulation service, psychiatrist-led delivery, and insurance reimbursement model.
• MindPath Care Centers: Outpatient psychiatric and behavioral health provider offering therapy, medication management, and TMS across multiple states. Comparable in combining psychiatric outpatient services with TMS treatment as part of an integrated behavioral health offering.
• Greenbrook TMS / Novamind: Largest dedicated U.S. chain of TMS clinics offering Deep TMS and related neurostimulation therapies for depression and OCD. Directly comparable given similar outpatient TMS service model, insurance-reimbursement revenue, and multi-site partner/affiliated clinic footprint.
• Achieve TMS: Multi-state TMS clinic franchise network providing insurance-covered transcranial magnetic stimulation for depression and other conditions. Closely comparable business model: partner/affiliate psychiatrist practices delivering TMS treatments with centralized marketing and credentialing support.
• Active TMS Therapy: Outpatient TMS clinic chain offering depression and anxiety treatment via partner psychiatrists with insurance billing. Directly comparable in scale, service line, and patient population to TMS Clinical Solutions' clinical arm.

Emerging players

• Cerebral: Direct-to-consumer online mental health platform offering therapy and medication management. Comparable as an alternative channel for the same treatment-resistant depression patient population; partial overlap in target use case but distinct delivery (telehealth vs. in-clinic TMS).
• Talkspace: Online therapy and psychiatry platform serving employers and consumers. Comparable in serving the broader mental health treatment population, including many of the same depression and anxiety patients who could alternatively pursue TMS; an indirect/adjacent competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/TMSClinicalSolutions
• LinkedInlinkedin.com/company/tmsclinicalsolutions

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Tms Clinical Solutions